Industries - Injectable Drug Delivery Technologies Market Analysis by Drug Delivery (Formulations, Devices), by Therapeutic Use (Hormonal Disorders, Autoimmune Disorders, Oncology), by End User (Homecare Settings, Hospital) and by Region – Forecast to 2026

Ablation Technology Market Analysis

Injectable Drug Delivery Technologies Market Analysis by Drug Delivery (Formulations, Devices), by Therapeutic Use (Hormonal Disorders, Autoimmune Disorders, Oncology), by End User (Homecare Settings, Hospital) and by Region – Forecast to 2026
July 2021

SKU: N/A Category:
Clear
  • Description
  • Additional information
  • Enquire about

Description

Injectable Drug Delivery Technologies Market Analysis by Drug Delivery (Formulations, Devices), by Therapeutic Use (Hormonal Disorders, Autoimmune Disorders, Oncology), by End User (Homecare Settings, Hospital) and by Region - Forecast to 2026

Published: July-21 | Historical Data: 2018-2020 | Base Year: 2020
SKU: ICI-HC-1206| Number of Pages: 148 | Category: Medical Devices

” The global injectable drug delivery technologies market size is projected to reach USD 1133.9 billion by 2026, exhibiting a compounded annual growth rate (CAGR) of 11.7% during the forecast period 2020-2026. “

Drug delivery systems are engineered technologies used in the targeted delivery for controlled release of therapeutic agents. In the past few decades, the practice of drug delivery has changed dramatically and even better changes are anticipated in the near future. For the understanding of physiological barriers such as transport of drug in the circulatory system, biomedical engineers have contributed to the development of new modes of drug delivery for clinical practice. Drug delivery can be achieved through various routes such as inhalation, swallowing, absorption or by injection. The use of self-injectable drug delivery devices such as pen injectors and needle free injectors have made it easier for the patients and caregivers to administer drugs at home without any assistance from medical practitioners.

Acceleration in the global demand for self- injection devices is a key driver for the growth of the global injectable drug delivery technologies market. Additionally, the surge in the number of patients suffering from chronic diseases and high rate of technological innovation in the injectable drug delivery technologies market are some of the other drivers propelling the market growth. For instance, it is estimated that around 4% of the world’s population is affected by autoimmune diseases like rheumatoid arthritis, type 1 diabetes, multiple sclerosis etc. Moreover, rising incidence of needle stick injuries and preference for alternative modes of drug delivery is expected to restrain the global market growth.

Injectable Drug Delivery Technologies Market

Read more about the market dynamics, Request a Sample Copy

Market Driver Analysis

Surge in the number of patients suffering from chronic diseases leading to increase in market growth

The prevalence of chronic diseases like autoimmune, cancer, hormonal disorders is increasing across the globe. Approximately, these chronic diseases kill 4.1 million people which makes to 71% of all the deaths globally. The third most common cause of chronic illness in the U.S. is the autoimmune diseases. According to the National Institutes for Health (NIH) it is estimated that around 5% to 8% percent of the U.S. population is affected by autoimmune diseases. The most common autoimmune disease includes Diabetes, Crohn’s Disease, Rheumatoid Arthritis (RA), Scleroderma, Psoriasis. In 2019, according to the International Diabetes Federation, there were approximately 463 million adults in the age group of 20-79 years affected and 4.2 million deaths due to diabetes. Thus, rising number of patients with chronic disease is further contributing to the increased adoption of injectable drug delivery technologies globally.

 

Acceleration in the global demand for self-injection devices propels the market growth

Biologics are becoming more specialized and patient centric. The devices for self-injection which includes autoinjectors and pens for subcutaneous delivery are a growing segment in the world of drug delivery devices. With the increase in the chronic diseases like diabetes, hormone replacement, multiple sclerosis, the drug delivery devices market is the core driver for the development of self-injection without any medical assistance. Hence, key market players are focusing on developing novel and technologically advanced self-injecting devices to provide added benefits to patients and caregivers. For instance, in October 2019, Becton, Dickinson and Company, one of the leading companies offering medical technology products, announced the launch of its BD Intevi 1mL disposable autoinjector device. This two-step injector combines the autoinjector with the pre-fillable syringe in one integrated system.

 

Key Market Restraint

Preference for alternative modes of drug delivery

The injectable drug delivery device market has been negatively affected due to the emergence of alternative drug delivery devices. Other than the injectable drug delivery devices there are many alternative drug delivery systems such as transdermal, nasal, vaginal, transmucosal, and anal. The drug delivery device is selected on the basis of the drug release, absorption, distribution metabolism, safety and the efficiency of the drug. The device which has the highest efficacy in treating the chronic disease holds key importance in the market. The frequent innovations and formulations in the therapeutic areas drive the need for alternative drug delivery systems. Due to these factors the alternative drug delivery devices hamper the growth of the injectable drug device market.

 

Market Segmentation and Share Analysis

By Drug Delivery

Based on drug delivery, the market is segmented into formulations and devices. In 2020, the formulations segment accounted for the maximum revenue share and is expected to witness a lucrative CAGR during the forecast period. This is attributed to increasing investment in R&D and the usage of colloidal dispersions in the drug delivery systems. The devices segment is projected to grow at a significant CAGR during the forecast period. This is attributed to the increasing use of these devices as they help in the management and control of several disorders at the initial level.

By Therapeutic Use

Based on therapeutic use, the market is categorized into hormonal disorders, autoimmune disorders, oncology, and others. In 2020, the oncology segment accounted for the maximum revenue share which is attributed to the increasing use of chemotherapy for the treatment of cancer using injectable drug delivery devices globally. The hormonal disorders segment is anticipated to grow at a significant CAGR during the forecast period, due to the launch of new products and shift towards the treatment of growth hormone deficiency.

By End User

Based on end user, the market is categorized into homecare settings, hospital, and others. In 2020, the homecare settings segment accounted for the largest revenue share. This is due to the increase in the number of patients who are able to administer drugs at home without any medical help. The hospital segment is anticipated to grow at a fastest CAGR during the forecast period, due to the increasing number of patients suffering from chronic diseases globally.

Regional Insights

In 2020, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the favorable repayment scenarios, presence of major players in the region, and accessibility of technologically advanced products in the region. For instance, in April 2020, Teva Pharmaceuticals announced the availability of autoinjector device for AJOVY injection in the U.S. market which is used for preventive migraine treatment.

North America Injectable Drug Delivery Technologies Market Size (2018-2026), USD Billion

North America Injectable Drug Delivery Technologies Market

Read more about the market dynamics, Request a Sample Copy

Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to availability of advanced devices, less stringent regulations, growing government and corporate investment in the healthcare sector, large population in various countries in the region, and availability of skilled labour forces at economic costs. For instance, in 2020, Cadilla Pharmaceuticals launched Cadalimab (40mg/0.8ml) injection which is used for the treatment of autoimmune diseases.

Competitor Insights

Some of the key players in the injectable drug delivery technologies market are Pfizer, Inc. (U.S.); Baxter International, Inc. (U.S.); Schott AG (Germany); Becton, Dickinson and Company (U.S.); Eli Lilly and Company (U.S.); Alkermes PLC (Ireland); Terumo Corporation (Japan); Elcam Medical (Israel); Unilife Corporation (U.S.); and Ypsomed (Switzerland). The leading players operating in the injectable drug delivery technologies industry are adopting various strategies including R&D investments, new product launch, mergers & acquisitions, and regional expansions to capture a maximum revenue share.

Industry Developments

  • In November 2020, Ypsomed collaborated with Schottand Lonza to offer the YpsoDose patch injector platform as fully integrated solution. This injector platform is used for the subcutaneous self-administration of high volumes of drugs.
  • In June 2020, Eli Lilly and Company’s announced the approval of Lyumjev (insulin lispro-aabc injection) by the S.FDA. Lyumjev is a formulation of insulin lispro indicated to improve the glycaemic control among adults suffering from diabetes.

Research Scope and Segments

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2018 to 2026. The injectable drug delivery technologies market report is categorized into the following segments and subsegments:

Injectable Drug Delivery Technologies Market, By Drug Delivery (Revenue, USD Billion, 2018 – 2026)

  • By Formulations
    • Conventional Drug Delivery
    • Novel Drug Delivery
    • Others
  • By Devices
    • Self-Injection Devices
    • Conventional Devices

Injectable Drug Delivery Technologies Market, By Therapeutic Use (Revenue, USD Billion, 2018 – 2026)

  • Hormonal Disorders
  • Autoimmune Disorders
  • Oncology
  • Others

Injectable Drug Delivery Technologies Market, By End User (Revenue, USD Billion, 2018 – 2026)

  • Homecare Settings
  • Hospital
  • Others

Injectable Drug Delivery Technologies Market, By Region (Revenue, USD Billion, 2018 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Injectable Drug Delivery Technologies Market Report:

Key Parameters Details
Data Availability 2018-2026
Historical Years 2018-2020
Base Year Considered 2020
Forecast Data 2021-2026
Company Profiles 10
Companies Considered >40
Value Units Value in USD and CAGR in %
Market Segments Drug Delivery, Therapeutic Use, and End User
Regional Coverage
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • Middle East & Africa (South Africa, Saudi Arabia, Rest of MEA)
Key Market Players
  • Pfizer, Inc.
  • Baxter International, Inc.
  • Schott AG
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Alkermes PLC
  • Terumo Corporation
  • Elcam Medical
  • Unilife Corporation
  • Ypsomed
Custom Analysis Customization up to 60 analyst hours (15%)

Injectable Drug Delivery Technologies Market, By Drug Delivery (Revenue, USD Billion, 2018 – 2026)

  • By Formulations
    • Conventional Drug Delivery
    • Novel Drug Delivery
    • Others
  • By Devices
    • Self-Injection Devices
    • Conventional Devices

Injectable Drug Delivery Technologies Market, By Therapeutic Use (Revenue, USD Billion, 2018 – 2026)

  • Hormonal Disorders
  • Autoimmune Disorders
  • Oncology
  • Others

Injectable Drug Delivery Technologies Market, By End User (Revenue, USD Billion, 2018 – 2026)

  • Homecare Settings
  • Hospital
  • Others

Injectable Drug Delivery Technologies Market, By Region (Revenue, USD Billion, 2018 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA
1. Research Methodology
 1.1. Research Objective
 1.2. Study Scope: Market Segments
 1.3. Study Timeframe, Limitations & Currency
 1.4. Domain-Assisted Cognition (DAC) Framework
  1.4.1. Three-stage Research Methodology
   1.4.1.1. Understand Ecosystem
    1.4.1.1.1. Secondary Research
    1.4.1.1.2. Primary Research
    1.4.1.1.3. Internal Repository
   1.4.1.2. Synthesize Information
    1.4.1.2.1. Data Analysis
    1.4.1.2.2. Data Triangulation
   1.4.1.3. Predict/Project Growth
    1.4.1.3.1. Market Size Estimation
     1.4.1.3.1.1. Bottom-up Approach
     1.4.1.3.1.2. Top-down Approach
     1.4.1.3.2. Data Validation
  1.4.2. Two-stage Quality Check Mechanism
   1.4.2.1. Inspection & Reporting
   1.4.2.2. Quality Audit
2. Market Summary
 2.1. Market Definition & Market Landscape
 2.2. Market Segment Snapshot
 2.3. Geographic Market Snapshot
3. Market Dynamics
 3.1. Market Driver Analysis
  3.1.1. Acceleration in the global demand for self- injection devices
  3.1.2. Surge in the number of patients suffering from chronic diseases
  3.1.3. High rate of technological innovation in the market
  3.1.4. Growth in the biologics market
 3.2. Market Restraint Analysis
  3.2.1. Rising incidence of needle stick injuries
  3.2.2. Preference for alternative modes of drug delivery
  3.2.3. Unproductiveness of injectable devices
 3.3. Market Opportunities
  3.3.1. Research and development activities backed by government
  3.3.2. Considered initiatives by key players to attain larger market share
  3.3.3. Market opportunities in developing countries for injectable technologies
4. Industry Outlook
 4.1. Key Market Trends
 4.2. Value Chain Analysis
 4.3. Porter’s 5 Forces Analysis
 4.4. Pricing Analysis (2018-2020)
 4.5. Product Benchmarking
5. Covid-19 Impact and Deviation Analysis
 5.1. Covid-19 Prevalence Analysis
 5.2. Key Market Trends
 5.3. Market Size Deviation Analysis (2020-2026)
6. Injectable Drug Delivery Technologies Market Size and Forecast, by Drug Delivery (2018-2026), USD Billion
 6.1. By Formulations
  6.1.1. Conventional drug delivery
  6.1.2. Novel drug delivery
  6.1.3. Others
 6.2. By Devices
  6.2.1. Self-Injection devices
  6.2.2. Conventional devices
7. Injectable Drug Delivery Technologies Market Size and Forecast, by Therapeutic Area (2018-2026), USD Billion
 7.1. Hormonal disorders
 7.2. Autoimmune disorders
 7.3. Oncology
 7.4. Others
8. Injectable Drug Delivery Technologies Market Size and Forecast, by End User (2018-2026), USD Billion
 8.1. Homecare Settings
 8.2. Hospital
 8.3. Others
9. Injectable Drug Delivery Technologies Market, Regional Analysis (2018-2026), USD Billion
 9.1. North America
  9.1.1. Introduction
   9.1.1.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.1.1.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.1.1.3. Market Size & Forecast, by End User (2018-2026), USD Billion
   9.1.1.4. Market Size & Forecast, by Country (2018-2026), USD Billion
  9.1.2. U.S.
   9.1.2.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.1.2.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.1.2.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.1.3. Canada
   9.1.3.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.1.3.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.1.3.3. Market Size & Forecast, by End User (2018-2026), USD Billion
 9.2. Europe
  9.2.1. Introduction
   9.2.1.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.2.1.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.2.1.3. Market Size & Forecast, by End User (2018-2026), USD Billion
   9.2.1.4. Market Size & Forecast, by Country (2018-2026), USD Billion
  9.2.2. Germany
   9.2.2.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.2.2.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.2.2.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.2.3. UK
   9.2.3.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.2.3.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.2.3.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.2.4. France
   9.2.4.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.2.4.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.2.4.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.2.5. Spain
   9.2.5.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.2.5.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.2.5.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.2.6. Italy
   9.2.6.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.2.6.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.2.6.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.2.7. Russia
   9.2.7.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.2.7.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.2.7.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.2.8. Rest of Europe
   9.2.8.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.2.8.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.2.8.3. Market Size & Forecast, by End User (2018-2026), USD Billion
 9.3. Asia Pacific (APAC)
  9.3.1. Introduction
   9.3.1.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.3.1.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.3.1.3. Market Size & Forecast, by End User (2018-2026), USD Billion
   9.3.1.4. Market Size & Forecast, by Country (2018-2026), USD Billion
  9.3.2. China
   9.3.2.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.3.2.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.3.2.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.3.3. Japan
   9.3.3.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.3.3.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.3.3.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.3.4. India
   9.3.4.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.3.4.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.3.4.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.3.5. Australia
   9.3.5.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.3.5.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.3.5.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.3.6. South Korea
   9.3.6.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.3.6.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.3.6.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.3.7. Rest of Asia Pacific
   9.3.7.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.3.7.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.3.7.3. Market Size & Forecast, by End User (2018-2026), USD Billion
 9.4. Latin America (LATAM)
  9.4.1. Introduction
   9.4.1.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.4.1.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.4.1.3. Market Size & Forecast, by End User (2018-2026), USD Billion
   9.4.1.4. Market Size & Forecast, by Country (2018-2026), USD Billion
  9.4.2. Brazil
   9.4.2.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.4.2.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.4.2.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.4.3. Mexico
   9.4.3.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.4.3.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.4.3.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.4.4. Argentina
   9.4.4.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.4.4.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.4.4.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.4.5. Rest of LATAM
   9.4.5.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.4.5.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.4.5.3. Market Size & Forecast, by End User (2018-2026), USD Billion
 9.5. Middle East & Africa (MEA)
  9.5.1. Introduction
   9.5.1.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.5.1.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.5.1.3. Market Size & Forecast, by End User (2018-2026), USD Billion
   9.5.1.4. Market Size & Forecast, by Country (2018-2026), USD Billion
  9.5.2. South Africa
   9.5.2.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.5.2.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.5.2.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.5.3. Saudi Arabia
   9.5.3.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.5.3.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.5.3.3. Market Size & Forecast, by End User (2018-2026), USD Billion
  9.5.4. Rest of MEA
   9.5.4.1. Market Size & Forecast, by Drug Delivery (2018-2026), USD Billion
   9.5.4.2. Market Size & Forecast, by Therapeutic Use (2018-2026), USD Billion
   9.5.4.3. Market Size & Forecast, by End User (2018-2026), USD Billion
10. Competitor Analysis
 10.1. Market Player Comparison
 10.2. Product-wise Player Mapping
 10.3. Region-wise Player Mapping
 10.4. Market Share Analysis
 10.5. Market Position Analysis
 10.6. Recent Development Analysis
11. Company Profiles
 11.1. Pfizer, Inc. (U.S.)
  11.1.1. Company Overview
  11.1.2. Company Financials
  11.1.3. Product Portfolio
  11.1.4. Recent Developments
 11.2. Baxter International, Inc. (U.S.)
  11.2.1. Company Overview
  11.2.2. Company Financials
  11.2.3. Product Portfolio
  11.2.4. Recent Developments
 11.3. Schott AG (Germany)
  11.3.1. Company Overview
  11.3.2. Company Financials
  11.3.3. Product Portfolio
  11.3.4. Recent Developments
 11.4. Becton, Dickinson and Company (U.S.)
  11.4.1. Company Overview
  11.4.2. Company Financials
  11.4.3. Product Portfolio
  11.4.4. Recent Developments
 11.5. Eli Lilly and Company (U.S.)
  11.5.1. Company Overview
  11.5.2. Company Financials
  11.5.3. Product Portfolio
  11.5.4. Recent Developments
 11.6. Alkermes PLC (Ireland)
  11.6.1. Company Overview
  11.6.2. Company Financials
  11.6.3. Product Portfolio
  11.6.4. Recent Developments
 11.7. Terumo Corporation (Japan)
  11.7.1. Company Overview
  11.7.2. Company Financials
  11.7.3. Product Portfolio
 11.8. Elcam Medical (Israel)
  11.8.1. Company Overview
  11.8.2. Company Financials
  11.8.3. Product Portfolio
  11.8.4. Recent Developments
 11.9. Unilife Corporation (U.S.)
  11.9.1. Company Overview
  11.9.2. Company Financials
  11.9.3. Product Portfolio
  11.9.4. Recent Developments
 11.10. Ypsomed (Switzerland)
  11.10.1. Company Overview
  11.10.2. Company Financials
  11.10.3. Product Portfolio
  11.10.4. Recent Developments
(Note: Financials are captured for public listed companies)

Key questions addressed by the research report-

Historic Period: 2018-2020, Base Year: 2020, Forecast Data: 2021-2026

Injectable Drug Delivery Technologies Market exhibits a compounded annual growth rate (CAGR) of 11.7 % from 2020 to 2026

Prominent players in the Injectable Drug Delivery Technologies Market are Pfizer Inc., Baxter International, Inc., Schott AG, Becton, Dickinson and Company, Eli Lilly and Company, Alkermes PLC, Terumo Corporation, Elcam Medical, Unilife Corporation and Ypsomed

North America and Asia Pacific offers numerous growth opportunities for companies operating in the Injectable Drug Delivery Technologies Market.

Formulations segment leads the Drug Delivery market segment in 2020

Yes, the report offers comprehensive analysis of the COVID-19 pandemic on the market. The report comes with in-depth deviation analysis pre- and post-COVID-19 along with the market trends during the study period.

We follow our in-house domain-assisted cognition (DAC) research framework to compose all our market research reports. The framework ensures contextually relevant insights discovery by collecting precise market information via primary and secondary research.

Yes, we offer 15% free customization with the purchase of this report. Please Contact Us regarding your customization requirements and our research expert will connect with you within 12 hours.


    Have any question? Check your free sample before purchase or connect with our expert.

    Additional information

    Licensing Types

    , , ,

    Enquire about Injectable Drug Delivery Technologies Market Analysis by Drug Delivery (Formulations, Devices), by Therapeutic Use (Hormonal Disorders, Autoimmune Disorders, Oncology), by End User (Homecare Settings, Hospital) and by Region - Forecast to 2026